Cellebrite DI Ltd.
Cellebrite DI Ltd.
Your view on CLBT
Overview
What the company does, where it operates, and who runs it.
About Cellebrite DI Ltd.
- Industry
- Software - Infrastructure
- Sector
- Technology
- CEO
- Thomas E. Hogan
- Headquarters
- 94 Shlomo Shmelzer Road, Petah Tikva, IL
- Industry
- Software - Infrastructure
- Sector
- Technology
- CEO
- Thomas E. Hogan
- Headquarters
- 94 Shlomo Shmelzer Road, Petah Tikva, IL
Cellebrite DI Ltd. develops solutions for legally sanctioned investigations.
Its DI platform allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations and solutions are used in a various case, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, intellectual property theft, and civil litigation.
The company's Universal Forensic Extraction Device solution addresses problems in accessing digital information, including complicated device locks, encryption barriers, deleted and unknown content, and other obstacles that can prevent critical evidence from coming to light.
It also offers Seeker solution that provides the ability to analyze video footage; OSINT Analyze, a real-time deep dive solution used to analyze open-source information, such as the surface web, deep web, and the dark web; and Crypto Tracer, which analyzes blockchain transactions together with related data from an extensive list of sources to identify and categorize wallets, and transactions.
The company serves federal and state and local agencies, as well as enterprise companies and service providers. It has operations in the United States, Germany, Singapore, Australia, Brazil, United Kingdom, France, Canada, Japan, and India. The company was incorporated in 1999 and is based in Petah Tikva, Israel.
Cellebrite Mobile Synchronization Ltd. operates as a subsidiary of Sun Corporation.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Cellebrite DI Ltd., and the rating behind it. CLBT last traded at $11.23, 47.9× trailing earnings — the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Cellebrite DI Ltd.. Starting points for Cellebrite DI Ltd.: P/E 47.9, EPS $0.24, beta 1.15 — an Software - Infrastructure name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Cellebrite DI Ltd.. Cellebrite DI Ltd. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Cellebrite DI Ltd.. Trailing twelve-month EPS for Cellebrite DI Ltd. stands at $0.24. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Cellebrite DI Ltd.. Cellebrite DI Ltd. has reported as a listed company since 2020. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Cellebrite DI Ltd. valued side by side against its closest peers. Cellebrite DI Ltd. is measured against Software - Infrastructure peers within the Technology sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Cellebrite DI Ltd., and how their positions are changing. At a $2.80B market value, institutional positions materially move Cellebrite DI Ltd.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Cellebrite DI Ltd. executives and directors. Shares of Cellebrite DI Ltd. have traded between $13.10 and $26.30 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Cellebrite DI Ltd.. Cellebrite DI Ltd. is a $2.80B Technology company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Cellebrite DI Ltd.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Cellebrite DI Ltd.. Coverage tracks Cellebrite DI Ltd. within Software - Infrastructure (Technology). Press releases and market coverage, newest first.